NASDAQ: PBAX - Phoenix Biotech Acquisition Corp.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Financials

Share chart Phoenix Biotech Acquisition Corp.


About Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.


IPO date 2021-11-30
ISIN US71902K1051
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Сайт https://www.phoenixbiotechacquisitioncorp.com
Цена ао 4.9
Change price per day: 0% (4.9)
Change price per week: 0% (4.9)
Change price per month: 0% (4.9)
Change price per 3 month: 0% (4.9)
Change price per half year: 0% (4.9)
Change price per year: -55.45% (11)
Change price per 3 year: -50.55% (9.91)
Change price per 5 year: 0% (4.9)
Change price per 10 year: 0% (4.9)
Change price per year to date: 0% (4.9)

Underestimation

Title Value Grade
P/S 719.84 1
P/BV 74.31 1
P/E 0 0
EV/EBITDA -31.98 0
Total: 0.625

Efficiency

Title Value Grade
ROA, % -0.6004 0
ROE, % -0.7706 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.114 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1629.61 10
Yield EPS, % 2336.5 10
Total: 8



Head Job title Payment Year of birth
Mr. Christopher B. Ehrlich M.B.A. CEO & Director N/A 1970 (55 years)
Dr. Douglas Carl Fisher M.B.A., M.D. President N/A 1976 (49 years)
Mr. Daniel E. Geffken M.B.A. Chief Financial Officer N/A 1957 (68 years)

Address: United States, Oakland. CA, 2201 Broadway - open in Google maps, open in Yandex maps
Website: https://www.phoenixbiotechacquisitioncorp.com